it is prepared per patient prescription by a US-licensed compounding pharmacy
Commonly reported side effects in the Phase 2 trial included: Nausea (the most frequently reported adverse effect) Vomiting Diarrhoea Constipation Decreased appetite Abdominal discomfort or bloating Eructation (belching) The majority of participants who discontinued treatment did so due to gastrointestinal side effects, underscoring the importance of the slow titration schedule used in trials
Results vary, but many people notice appetite changes within the first few weeks
Gastrointestinal effects Nausea dominates the side effect landscape
For women balancing hormonal change, career demands, caregiving responsibilities, and lifestyle stressors, optimizing sleep may be one of the most powerful metabolic interventions available
Saniona AB Saniona's partner Medix receives favorable opinion for tesofensine for the treatment of obesity in Mexico